Commentary

On bias and transparency in the development of influential recommendations

Andreas Laupacis
CMAJ January 31, 2006 174 (3) 335-336; DOI: https://doi.org/10.1503/cmaj.051622

Article Information

vol. 174 no. 3 335-336
DOI 
https://doi.org/10.1503/cmaj.051622
PubMed 
16446476
History 
  • Published online January 30, 2006.
Copyright & Usage 
© 2006 CMA Media Inc. or its licensors

Author Information

  1. Andreas Laupacis
  1. Andreas Laupacis is with the Institute for Clinical Evaluative Sciences and the University of Toronto, Toronto, Ont.
  1. Correspondence to:
    Dr. Andreas Laupacis, Institute for Clinical Evaluative Sciences, 2075 Bayview Ave., Rm. G106, Toronto ON M5N 3M5; fax 416 480-6048; andreas.laupacis{at}ices.on.ca

Statistics from Altmetric.com

Usage statistics: January 2009 to May 2023

AbstractFullPdf
Jan 200901311
Feb 20090105
Mar 20090175
Apr 20090225
May 20090177
Jun 2009066
Jul 20090165
Aug 2009083
Sep 20090106
Oct 20090105
Nov 2009078
Dec 2009082
Jan 20100125
Feb 2010065
Mar 20100107
Apr 2010072
May 20100122
Jun 20100104
Jul 20100178
Aug 2010054
Sep 2010035
Oct 2010086
Nov 2010084
Dec 20100135
Jan 20110127
Feb 2011074
Mar 20110156
Apr 2011065
May 2011073
Jun 20110124
Jul 2011073
Aug 2011058
Sep 20110123
Oct 20110325
Nov 20110436
Dec 20110285
Jan 20120384
Feb 20120115
Mar 20120203
Apr 20120215
May 20120308
Jun 20120239
Jul 20120369
Aug 2012075
Sep 20120164
Oct 20120204
Nov 20120181
Dec 20120184
Jan 20130364
Feb 20130161
Mar 20130172
Apr 20130372
May 20130115
Jun 2013081
Jul 2013032
Aug 20130110
Sep 2013041
Oct 20130110
Nov 20130144
Dec 2013041
Jan 20140102
Feb 20140112
Mar 2014050
Apr 20140295
May 20140241
Jun 2014040
Jul 2014031
Aug 20140112
Sep 2014084
Oct 20140111
Nov 2014091
Dec 20140128
Jan 2015070
Feb 20150103
Mar 20150113
Apr 2015010
May 20150120
Jun 20150101
Jul 2015040
Aug 2015081
Sep 2015070
Oct 2015060
Nov 20150231
Dec 20150244
Jan 20160256
Feb 20160112
Mar 20160105
May 2016092
Jun 2016091
Jul 20160170
Aug 2016086
Sep 20160145
Oct 20160153
Nov 20160110
Dec 20160121
Jan 20170130
Feb 20170161
Mar 20170155
Apr 20170150
May 20170181
Jun 2017060
Jul 2017091
Aug 20170131
Sep 20170102
Oct 20170201
Nov 2017092
Dec 20170252
Jan 20180311
Feb 20180294
Mar 20180281
Apr 20180321
May 20180351
Jun 20180492
Jul 20180251
Aug 20180112
Sep 2018091
Oct 20180272
Nov 20180121
Dec 2018093
Jan 20190104
Feb 20190104
Mar 2019096
Apr 2019074
May 20190102
Jun 2019062
Jul 2019083
Aug 2019032
Sep 2019032
Oct 2019063
Nov 2019073
Dec 2019084
Jan 2020084
Feb 2020032
Mar 2020052
Apr 2020030
May 2020043
Jun 2020031
Jul 2020093
Aug 2020090
Sep 2020094
Oct 20200194
Nov 202001413
Dec 2020075
Jan 20210205
Feb 2021026
Mar 20210152
Apr 20210132
May 20210144
Jun 20210113
Jul 2021066
Aug 2021093
Sep 2021044
Oct 20210621
Nov 202101512
Dec 2021071
Jan 2022049
Feb 2022073
Mar 20220154
Apr 2022064
May 20220127
Jun 20220177
Jul 202201312
Aug 2022047
Sep 2022096
Oct 20220128
Nov 20220147
Dec 202201011
Jan 20230546
Feb 2023051
Mar 2023060
Apr 2023075
May 2023040

Cited By...

Back to top

In this issue

Canadian Medical Association Journal: 174 (3)
CMAJ
Vol. 174, Issue 3
31 Jan 2006

Article tools

Respond to this article
Print
Download PDF
Article Alerts
Email Article
Citation Tools
On bias and transparency in the development of influential recommendations
Andreas Laupacis
CMAJ Jan 2006, 174 (3) 335-336; DOI: 10.1503/cmaj.051622
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Collections

 

View Latest Classified Ads